Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

BioAge Labs (BIOA) Other Non-Current Assets (2024 - 2025)

BioAge Labs (BIOA) has disclosed Other Non-Current Assets for 2 consecutive years, with $216000.0 as the latest value for Q4 2025.

  • Quarterly Other Non-Current Assets fell 10.0% to $216000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $216000.0 through Dec 2025, down 10.0% year-over-year, with the annual reading at $216000.0 for FY2025, 10.0% down from the prior year.
  • Other Non-Current Assets hit $216000.0 in Q4 2025 for BioAge Labs, down from $227000.0 in the prior quarter.
  • In the past five years, Other Non-Current Assets ranged from a high of $240000.0 in Q4 2024 to a low of $216000.0 in Q4 2025.